"Comprehensive Pain & Neurology Center is Middle Tennessee's comprehensive resource for chronic pain treating. With multiple locations across Middle Tennessee, we provide patients with interventional procedures and therapies to help relieve their pain and reclaim their lives."

During the past decade, Comprehensive Pain Specialists conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Pain Specialists" #1 sponsor was "Pfizer" with 3 trials, followed by "Cephalon" with 2 trials sponsored, "Cumberland Pharmaceuticals" with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Pain Specialists" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Pain Specialists" are "Chronic Pain" (3 trials), "Pain" (3 trials), "Opioid-Induced Bowel Dysfunction" (2 trials), "Pain, Postoperative" (2 trials) and "Breakthrough Pain" (1 trials). Many other conditions were trialed in "Comprehensive Pain Specialists" in a lesser frequency.

Most popular intervention types in "Comprehensive Pain Specialists" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Intravenous ibuprofen" (2 trials), "ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)" (1 trials), "Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER)" (1 trials) and "DIC075V (intravenous diclofenac sodium)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Pain Specialists" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Comprehensive Pain Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Comprehensive Pain Specialists, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Pain Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".